The GENESIS Platform
GENESIS is a revolutionary platform at the intersection of four cutting-edge technologies developed for over 7 years at Gnubiotics. Through rational design of glycan-conjugates, GENESIS tackles unmet needs in oncology and various diseases with unprecedented precision and innovation. By synergizing these disciplines, GENESIS pioneers novel solutions, leveraging the power of AI-driven design to engineer targeted therapies and diagnostics. With its multidimensional approach, GENESIS holds the promise to reshape the landscape of medical research, offering hope and tangible advancements in the fight against complex diseases, ushering in a new era of tailored treatment strategies.
Glycopeptides:
mastered the rational design and development of a series of important biologic therapeutics.
Generative AI:
Biomarker activity is leading to a material database where generative AI is being applied to further predict, discover, and develop new therapeutic opportunities.
High-Resolution Sequencing:
developed important technologies from its high-res sequencing capabilities to ID key predictive biomarkers.
CMC:
mastered a unique and proprietary method to produce at ton scale and to further manufacture all its biologics therapeutics.